AbbVie (ABBV) vs AstraZeneca (AZN)
AbbVie (ABBV) and AstraZeneca (AZN) side by side: both in Healthcare, listed on New York Stock Exchange and London Stock Exchange. AbbVie is the larger of the two by approximate market capitalization (about 1.7×).
| Field | AbbVie | AstraZeneca |
|---|---|---|
| Legal name | AbbVie Inc. | AstraZeneca PLC |
| Ticker | ABBV | AZN |
| Exchange | New York Stock Exchange XNYS | London Stock Exchange XLON |
| Jurisdiction | United States | United Kingdom |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Market cap ≈ | $390bn | $230bn |
| Founded | 2013 | 1999 |
| Reporting currency | USD | GBP |
| LEI | FR5LCKFTG8054YNNRU85 | PY6ZZQWO2IZFZC3IOL08 |
| ISIN | US00287Y1091 | GB0009895292 |
| FIGI | BBG0025Y4RZ3 | BBG001SCNW31 |
| Index membership | S&P 500 | FTSE 100 |
| Held by (covered funds) | — | — |
AbbVie
Large pharmaceutical company spun off from Abbott in 2013, with immunology blockbusters Skyrizi and Rinvoq succeeding Humira, plus the Allergan aesthetics portfolio (Botox).
AstraZeneca
Anglo-Swedish pharmaceutical company formed by the 1999 merger of Astra AB and Zeneca Group, with major franchises in oncology, cardiovascular and rare diseases. One of the largest companies on the London Stock Exchange.
Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/abbvie · /api/v1/companies/astrazeneca